x |
QUARTERLY
REPORT PURSUANT TO SECTION 13 or 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
|
o |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE
ACT
|
59-2971472
|
|
I.R.S.
Employer ID No.
|
|
incorporation
or organization)
|
|
September
30,
2007
|
December
31, 2006
|
||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
17,647,647
|
$
|
13,225,528
|
|||
Accounts
receivable
|
104,082
|
-
|
|||||
Prepaid
expenses
|
691,930
|
1,025,132
|
|||||
Other
current assets
|
79,687
|
121,903
|
|||||
Total
current assets
|
18,523,346
|
14,372,563
|
|||||
PROPERTY
AND EQUIPMENT, net
|
1,919,633
|
2,094,300
|
|||||
OTHER
ASSETS, net
|
10,244,737
|
10,208,484
|
|||||
Total
assets
|
$
|
30,687,716
|
$
|
26,675,347
|
|||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable
|
$
|
732,561
|
$
|
382,489
|
|||
Accrued
expenses:
|
|||||||
Salaries
and wages
|
885,407
|
328,817
|
|||||
Professional
fees
|
355,861
|
231,372
|
|||||
Other
accrued expenses
|
177,378
|
116,713
|
|||||
Total
current liabilities
|
2,151,207
|
1,059,391
|
|||||
DEFERRED
RENT
|
368,197
|
433,340
|
|||||
Total
liabilities
|
2,519,404
|
1,492,731
|
|||||
COMMITMENTS
AND CONTINGENCIES
(Notes
7, 8, 9 and 10)
|
|||||||
SHAREHOLDERS'
EQUITY:
|
|||||||
Common
stock, $.01 par value, 100,000,000 shares authorized,
25,139,942 and 23,387,566 shares issued and
outstanding at September 30, 2007 and December 31, 2006
respectively
|
251,399
|
233,876
|
|||||
Warrants
outstanding
|
17,492,098
|
20,290,878
|
|||||
Additional
paid-in capital
|
173,363,525
|
154,056,663
|
|||||
Accumulated
deficit
|
(162,938,710
|
)
|
(149,398,801
|
)
|
|||
Total
shareholders' equity
|
28,168,312
|
25,182,616
|
|||||
Total
liabilities and shareholders' equity
|
$
|
30,687,716
|
$
|
26,675,347
|
Three
Months Ended September 30,
|
Nine
Months Ended
September
30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Service
revenue
|
$
|
194,129
|
$
|
-
|
$
|
283,675
|
$
|
-
|
|||||
Cost
of sales
|
174,629
|
-
|
251,314
|
-
|
|||||||||
Gross
margin
|
19,500
|
-
|
32,361
|
-
|
|||||||||
Research
and development expenses
|
2,782,933
|
2,273,264
|
8,073,005
|
7,361,191
|
|||||||||
Marketing
and selling expenses
|
630,312
|
513,956
|
1,977,867
|
1,590,715
|
|||||||||
General
and administrative expenses
|
1,484,914
|
1,257,904
|
4,185,289
|
4,198,183
|
|||||||||
Total
operating expenses
|
4,898,159
|
4,045,124
|
14,236,161
|
13,150,089
|
|||||||||
Interest
and other income
|
222,826
|
257,956
|
663,891
|
700,124
|
|||||||||
Net
loss
|
(4,655,833
|
)
|
(3,787,168
|
)
|
(13,539,909
|
)
|
(12,449,965
|
)
|
|||||
Unrealized
gain on securities
|
-
|
-
|
-
|
1,006
|
|||||||||
Comprehensive
loss
|
$
|
(4,655,833
|
)
|
$
|
(3,787,168
|
)
|
$
|
(13,539,909
|
)
|
$
|
(12,448,959
|
)
|
|
Basic
and diluted net loss per common
share
|
$
|
(0.19
|
)
|
$
|
(0.16
|
)
|
$
|
(0.55
|
)
|
$
|
(0.54
|
)
|
Three
Months Ended
September
30,
|
Nine
Months Ended
September
30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
||||
Net
loss
|
$
|
(4,655,833
|
)
|
$
|
(3,787,168
|
)
|
$
|
(13,539,909
|
)
|
$
|
(12,449,965
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||||||||
Depreciation
and amortization
|
424,345
|
422,395
|
1,232,838
|
1,287,631
|
|||||||||
Stock
compensation
|
665,491
|
435,600
|
1,676,086
|
1,921,873
|
|||||||||
Loss
(gain) on disposal of equipment
|
4,388
|
(7,251
|
)
|
17,313
|
(7,251
|
)
|
|||||||
Changes
in operating assets and liabilities:
|
|||||||||||||
Accounts
receivable, net
|
(14,536
|
)
|
-
|
(104,082
|
)
|
14,854
|
|||||||
Prepaid
expenses and other assets
|
(5,098
|
)
|
103,913
|
324,232
|
424,428
|
||||||||
Accounts
payable and accrued expenses
|
65,381
|
(157,580
|
)
|
1,085,603
|
556,469
|
||||||||
Deferred rent
|
(21,170
|
)
|
50,719
|
(58,930
|
)
|
511,584
|
|||||||
Total
adjustments
|
1,118,801
|
847,796
|
4,173,060
|
4,709,588
|
|||||||||
Net
cash used in operating activities
|
(3,537,032
|
)
|
(2,939,372
|
)
|
(9,366,849
|
)
|
(7,740,377
|
)
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||||||||
Purchases
of property and equipment
|
(25,800
|
)
|
(206,976
|
)
|
(391,745
|
)
|
(1,008,639
|
)
|
|||||
Payments
for patent costs
|
(237,934
|
)
|
(320,724
|
)
|
(695,563
|
)
|
(986,924
|
)
|
|||||
Proceeds
from maturing of investments
|
-
|
-
|
-
|
295,000
|
|||||||||
Proceeds
from sale of property and equipment
|
-
|
36,867
|
-
|
36,867
|
|||||||||
Net
cash used in investing activities
|
(263,734
|
)
|
(490,833
|
)
|
(1,087,308
|
)
|
(1,663,696
|
)
|
|||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||||||||
Proceeds
from issuance of common stock in private offering
|
-
|
-
|
8,400,249
|
16,246,850
|
|||||||||
Proceeds
from exercise of options and warrants
|
2,026,196
|
-
|
6,476,027
|
185,128
|
|||||||||
Net
cash provided by financing activities
|
2,026,196
|
-
|
14,876,276
|
16,431,978
|
|||||||||
NET
(DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS
|
(1,774,570
|
)
|
(3,430,205
|
)
|
4,422,119
|
7,027,905
|
|||||||
CASH
AND CASH EQUIVALENTS, beginning of period
|
19,422,217
|
20,731,745
|
13,225,528
|
10,273,635
|
|||||||||
CASH
AND CASH EQUIVALENTS, end of period
|
$
|
17,647,647
|
$
|
17,301,540
|
$
|
17,647,647
|
$
|
17,301,540
|
September
30, 2007
|
||||||||||
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Value
|
||||||||
Patents
and copyrights
|
$
|
14,121,717
|
$
|
4,296,823
|
$
|
9,824,894
|
||||
Prepaid
licensing fees
|
705,000
|
699,643
|
5,357
|
|||||||
Deposits
and other
|
414,486
|
-
|
414,486
|
|||||||
$
|
15,241,203
|
$
|
4,996,466
|
$
|
10,244,737
|
December
31, 2006
|
||||||||||
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Value
|
||||||||
Patents
and copyrights
|
$
|
13,426,154
|
$
|
3,706,477
|
$
|
9,719,677
|
||||
Prepaid
licensing fees
|
705,000
|
606,250
|
98,750
|
|||||||
Deposits
and other
|
390,057
|
-
|
390,057
|
|||||||
$
|
14,521,211
|
$
|
4,312,727
|
$
|
10,208,484
|
Three
months ended
September
30,
|
Nine
months ended
September
30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Cost
of sales
|
$
|
15,668
|
$
|
0
|
$
|
20,627
|
$
|
0
|
|||||
Research
and development expense
|
185,782
|
201,159
|
508,878
|
697,673
|
|||||||||
Sales
and marketing expense
|
131,493
|
72,705
|
328,586
|
261,261
|
|||||||||
General
and administrative expense
|
332,548
|
161,736
|
817,995
|
962,939
|
|||||||||
Total
share-based expense
|
$
|
665,491
|
$
|
435,600
|
$
|
1,676,086
|
$
|
1,921,873
|
|
|
Nine
months ended September 30, 2007
|
|
Nine
months ended September 30, 2006
|
Expected
volatility
|
|
66.6%
to 74.0%
|
|
69.4%
to 74.6%
|
Expected
life
|
|
4
to 7 years
|
|
4.25
to 7 years
|
Risk
free interest rate
|
|
4.36%
to 4.95%
|
|
4.18%
to 5.21%
|
Dividend
yield
|
|
-
|
|
-
|
|
Shares
(#)
|
Weighted-Average
Exercise
Price
($)
|
Weighted-Average
Remaining Contractual Term
|
Aggregate
Intrinsic Value ($)
|
|||||||||
Outstanding
at January 1, 2007
|
5,109,590
|
$
|
20.38
|
||||||||||
Granted
|
312,924
|
11.45
|
|||||||||||
Exercised
|
(121,008
|
)
|
7.97
|
$
|
535,707
|
||||||||
Expired
|
(493,083
|
)
|
17.79
|
||||||||||
Outstanding
at September 30, 2007
|
4,808,423
|
$
|
20.38
|
4.13
years
|
$
|
16,277,100
|
|||||||
Exercisable
at September 30, 2007
|
3,795,612
|
$
|
23.38
|
3.65
years
|
$
|
10,161,652
|
Shares
(#)
|
Weighted-Average
Grant-Date
Fair
Value ($)
|
||||||
Nonvested
at January 1, 2007
|
|
|
928,053
|
|
$
|
4.82
|
|
Granted
|
|
|
312,924
|
|
|
7.72
|
|
Vested
|
|
|
(228,166
|
)
|
|
4.48
|
|
Nonvested
at September 30, 2007
|
1,012,811
|
$
|
5.75
|
|
Shares
|
Weighted-Average
Exercise
Price
|
Weighted-Average
Remaining Contractual Term
|
Aggregate
Intrinsic Value ($)
|
|||||||||
Outstanding
at January 1, 2007
|
2,570,736
|
$
|
25.26
|
||||||||||
Exercised
|
(641,208
|
)
|
8.64
|
$
|
2,805,211
|
||||||||
Outstanding
at September 30, 2007
|
1,929,528
|
$
|
30.79
|
3.57
|
$
|
4,221,600
|
|||||||
Exercisable
at September 30, 2007
|
1,929,528
|
$
|
30.79
|
3.57
|
$
|
4,221,600
|
Date
of sale
|
|
Title
of security
|
|
Number
sold
|
|
Consideration
received and description of underwriting or other discounts to
market
price afforded to purchasers
|
|
Exemption
from registration claimed
|
|
If
option, warrant or convertible security, terms of exercise or
conversion
|
7/15/07-8/15/07
|
|
Options
to purchase common stock granted to employees pursuant to the 2000
Plan
|
|
56,671
|
Option
granted - no consideration received by Company until exercised
|
|
4(2)
|
Options
generally vest over a three year period and remain exercisable
for seven
years from the grant date at exercise prices ranging from $11.82
to $13.04
per share.
|
Date
of sale
|
|
Title
of security
|
|
Number
sold
|
|
Consideration
received and description of underwriting or other discounts to
market
price afforded to purchasers
|
|
Exemption
from registration claimed
|
|
If
option, warrant or convertible security, terms of exercise or
conversion
|
8/15/07
|
|
Options
to purchase common stock granted to non-employee directors pursuant
to the
2000 Plan
|
|
70,000
|
|
Option
granted - no consideration received by Company until exercised
|
|
4(2)
|
|
Options
vest 8/15/08 and remain exercisable for seven years from the grant
date at
an exercise price of $12.30 per share.
|
|
|
|
|
|
|
|
|
|
|
|
8/15/07
|
|
Options
to purchase common stock granted to executive officers pursuant
to the
2000 Plan
|
|
46,250
|
|
Option
granted - no consideration received by Company until exercised
|
|
4(2)
|
|
Options
vest over a three year period and remain exercisable for seven
years from
the grant date at an exercise price of $12.30 per
share.
|
|
|
|
|
|
|
|
|
|
|
|
9/4/07-9/27/07
|
|
Common
Stock
|
|
104,750
|
|
Received
proceeds of $942,750
|
|
4(2)
|
|
Exercise
of warrants issued in connection with private placement transaction
in
March 2005.
|
|
|
|
|
|
|
|
|
|
|
|
9/25/07-
9/27/07
|
|
Common
Stock
|
|
80,500
|
|
Received
proceeds of $684,251
|
|
4(2)
|
|
Exercise
of warrants issued in connection with private placement transaction
in
February 2006.
|
Votes
Cast
|
|||||||
Name
|
For
|
Withheld
|
|||||
Jeffrey
Parker
|
16,673,830
|
543,991
|
|||||
David
Sorrells
|
16,666,565
|
551,256
|
|||||
William
Hightower
|
16,646,315
|
571,506
|
|||||
John
Metcalf
|
17,035,863
|
181,958
|
|||||
Todd
Parker
|
16,429,913
|
787,908
|
|||||
Robert
Sterne
|
16,724,896
|
492,925
|
|||||
Nam
Suh
|
17,162,276
|
55,545
|
|||||
William
Sammons
|
17,153,143
|
64,678
|
|||||
Papken
der Torossian
|
17,157,245
|
60,576
|
3.1
|
Articles
of Incorporation, as amended (incorporated by reference from Exhibit
3.1
of Registration Statement No. 33-70588-A)
|
|
3.2
|
Amendment
to Amended Articles of Incorporation dated March 6, 2000 (incorporated
by
reference from Exhibit 3.2 of Annual Report on Form 10-K for the
year
ended December 31, 1999)
|
|
3.2
|
Bylaws,
as amended (incorporated by reference from Exhibit 3.1 of Current
Report
on Form 8-K filed August 10, 2007)
|
|
4.1
|
Shareholder
Protection Rights Agreement between the Registrant and American Stock
Transfer & Trust Company, as Rights Agent (incorporated by reference
from Exhibit 4.01 of Form 8-K dated November 21, 2005)
|
|
31.1
|
Section
302 Certification of Jeffrey L. Parker, CEO*
|
|
31.2
|
Section
302 Certification of Cynthia Poehlman, CFO*
|
|
32.1
|
Section
906 Certification*
|
* |
Filed
herewith.
|
1.
|
Form
8-K, dated August 10, 2007. Item 5.03 - Amendment to Bylaws to facilitate
direct share registration of the Company’s common stock in response to
NASDAQ rules requiring all traded stock be eligible for direct share
registration on or before January 1,
2008.
|
ParkerVision,
Inc.
Registrant
|
||
|
|
|
November 2, 2007 | By: | /s/Jeffrey L. Parker |
Jeffrey
L. Parker
Chairman
and Chief Executive Officer
|
November 2, 2007 | By: | /s/Cynthia L. Poehlman |
Cynthia
L. Poehlman
Chief
Financial Officer
|
31.1
|
Rule
13a-14 and 15d-14 Certification of Jeffrey Parker
|
|
31.2
|
Rule
13a-14 and 15d-14 Certification of Cynthia Poehlman
|
|
32.1
|
Section
1350 Certification of Jeffrey Parker and Cynthia
Poehlman
|